War on Vaping Threatens Public Health

War on Vaping Threatens Public Health
Will the government hamstring what is potentially the most important public health innovation of the 21st century?

Last week, the Food and Drug Administration announced “historic action” against e-cigarette manufacturers for what it sees as an “epidemic” of vaping among teenagers. E-cigarette makers have 60 days to come up with plans to mitigate teenage use of their products or face civil or criminal prosecution as well as new regulations such as sales bans on some of their products. 

Such a move could reverse recent stop-smoking achievements. While smoking rates have been declining steadily over the last half century, the pace has dramatically picked up in recent years as e-cigarettes have gained popularity.

If regulators don’t get in the way, e-cigarettes can continue to chip away at the one-in-six Americans who still smoke. This would be a major victory for public health. Smoking is still responsible for one in every five deaths. That is nearly three times more than the combined number of suicide, overdose, and alcohol-related deaths, whose rise has been attributed to the decline in U.S. life expectancy.

E-cigarettes are a comparably safe alternative that help people quit smoking because they deliver nicotine through water vapor — without the tar, smoke, carbon monoxide, and countless carcinogens in cigarettes.



 
Sign Up for Our Email Newsletter

RECENT NEWS

Streamline drug approval process

Streamline drug approval process

When Americans don't fill their prescriptions, their illnesses worsen, which drives up healthcare spending....  Read more

‘Transparency’ alone can’t convey the context or complexity of pricing drugs

‘Transparency’ alone can’t convey the context or complexity of pricing drugs

A key problem with Mr. Azar’s transparency effort is that it doesn’t provide consumers with any context or insights into ...  Read more

Safe Harbor Sunshine And Flat Fees: Vital Steps Towards Smarter Drug Spending

Safe Harbor Sunshine And Flat Fees: Vital Steps Towards Smarter Drug Spending

The current system encourages payers to favor medicines that carry higher rebates than lower list-priced drugs....  Read more

DRUGWONKS BLOG